Search - tctmd.com

Displaying 41 - 60 of 105

Sort: Relevancy | Date

Presentation TVT 2019

Updated PFO Closure for Cryptogenic Stroke, Migraine, and More…

Presenter: Mark Reisman

June 14, 2019

Presentation TVT 2019

Practicalities of Shared Decision-Making for Stroke Prevention: Relevance to LAA Occlusion and PFO Closure

Presenter: Megan Coylewright

June 14, 2019

Presentation TVT 2019

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

Presenter: Zahid Amin

June 14, 2019

Presentation TVT 2019

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

Presenter: Fabian Nietlispach

June 14, 2019

Presentation TVT 2019

PFO Closure for Conditions Beyond Cryptogenic Stroke

Presenter: Thomas Jones

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Presentation TVT 2019

The Evolut Low-Risk Randomized Trial

Presenter: Steven Yakubov

June 13, 2019

Presentation TVT 2019

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Presenter: Samir Kapadia

June 13, 2019

Presentation TVT 2019

Status Updates on the Next Generation of Cerebral Protection Devices

Presenter: Giora Weisz

June 13, 2019

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

Presentation TVT 2017

SURTAVI Vignette III: Subset Analysis of Strokes

Presenter: David J. Cohen, Jeffrey J. Popma, A. Pieter Kappetein

June 16, 2017

Presentation TVT 2017

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

Presenter: Axel Linke, Jeffrey J. Popma, Samir R. Kapadia

June 15, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Advertisement

Updated PFO Closure for Cryptogenic Stroke, Migraine, and More…

Practicalities of Shared Decision-Making for Stroke Prevention: Relevance to LAA Occlusion and PFO Closure

Operator and Institutional Requirements for PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke

PFO Closure for Secondary Prevention of Paradoxical Embolic Stroke: Randomized Trial Synthesis

PFO Closure for Conditions Beyond Cryptogenic Stroke

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

The PARTNER 3 Low-Risk Randomized Trial

The Evolut Low-Risk Randomized Trial

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Status Updates on the Next Generation of Cerebral Protection Devices

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

SURTAVI Vignette III: Subset Analysis of Strokes

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

Device Design Features and Findings From EU Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content